Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Immunocore Holdings (IMCR) Receivables Refunds: 2022-2023

  • Immunocore Holdings' Receivables Refunds fell 61.68% to $3.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.5 million, marking a year-over-year decrease of 61.68%. This contributed to the annual value of $3.5 million for FY2023, which is 61.68% down from last year.
  • Immunocore Holdings' Receivables Refunds amounted to $3.5 million in Q4 2023, which was up 357.37% from -$1.4 million recorded in Q3 2023.
  • Immunocore Holdings' Receivables Refunds' 5-year high stood at $9.2 million during Q4 2022, with a 5-year trough of -$1.4 million in Q3 2023.
  • Its 2-year average for Receivables Refunds is $3.8 million, with a median of $3.5 million in 2023.
  • Data for Immunocore Holdings' Receivables Refunds shows a maximum YoY tumbled of 61.68% (in 2023) over the last 5 years.
  • Immunocore Holdings' Receivables Refunds (Quarterly) stood at $9.2 million in 2022, then slumped by 61.68% to $3.5 million in 2023.
  • Its Receivables Refunds was $3.5 million in Q4 2023, compared to -$1.4 million in Q3 2023 and $9.2 million in Q4 2022.